Effects of oral iron(III) hydroxide polymaltose complex supplementation on hemoglobin increase, cognitive function, affective behavior and scholastic performance of adolescents with varying iron status: A single centre prospective placebo controlled study

Arzneimittel-Forschung/Drug Research

Volumn 59, Issue 6, 2009, Pages 303-310

  Devaki, Pallaki Baby ^a   Chandra, Ranjit K ^b   Geisser, Peter ^c  

^a SRI VENKATESWARA UNIVERSITY   (India)

^b Asthma and Immunology Centre   (India)

^c Vifor (International) Inc   (Switzerland)

Author keywords

Adolescents; Anemia; Antianemic drugs; Cognition; Iron deficiency; Iron(III) hydroxide polymaltose complex; Maltofer

Indexed keywords

HEMOGLOBIN; IRON POLYMALTOSE; MALTOFER; PLACEBO; UNCLASSIFIED DRUG;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; AFFECT; ARTICLE; CHILD BEHAVIOR; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BALANCE; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; MALE;

EID: 68549133369     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296401     Document Type: Article

References (27)

1. DeMayer E, Aaiels-Tegman M. The prevalence of anemia in the world. World Health Statistics Quarterly. 1985;138: 302-316.
2. Cook JD. Iron deficiency anaemia. Baillières Clin Haematol. 1994;7(4):787-814
3. Cook J. Finch C. Assessing iron status of a population. Am J Clin Nutr. 1979;32:2115-2119
4. Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szilagyi PG. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics. 2001;107:1381-1386 (Pubitemid 32525220)
5. Krishna Swamy KR, Sarma R. Health and nutritional status of women and adolescent girls in India in empowerment of women with special reference to women's health . Workshop by National Commission for Women. Tirupati (India): S. V. University; 2000. p. 47-58.
6. Kurz KM, Johnson-Welch C. The nutrition and lives of adolescents in developing countries: findings from the nutrition of adolescent girls research programme. Washington, DC: International Center for Research on Women [ICRW]; 1994. 34 p.
7. Voluntary Health Association of India (VHAI); 2005. Available from: http:www.pfzerindia.com/caring-healthcare.html.
8. Survival for Women and Children (SWACH) Foundation. Anemia in pregnant women and adolescent girls in Haryana . India Quarterly Progress Report; April to June 1997. Submitted Mother Care Project , Johnsnow, Inc.
9. De Maeyer, Dallman P, Gurney JM, Hallberg L, Sood SK, Srikantia. Preventing and controlling iron deficiency anemia through primary health care. Geneva: World Health Organization; 1989.
10. Horton S, Ross J. The economics of iron deficiency. Food Policy. 2003;28(1):51-75.
11. Felt BT, Lozoff B. Brain iron behaviour of rats are not normalized by treatment of iron deficiency anemia during early development. J Nutr 1996;126:693-701. (Pubitemid 26081179)
12. Hallberg L, Hutten L, Lindstedt G, Lundberg P, Mark A, Purens J, et al. Prevalence of iron deficiency in Swedish adolescents. Pediatr Res. 1993;34:680-687 (Pubitemid 23312803)
13. Seshadri S, Gopaldas T. Impact of iron supplementation and cognitive functions in preschool and school-aged children: The Indian experience. AmJ Clin Nutr. 1989;50:675-686 (Pubitemid 19227103)
14. Geisser P. Iron therapy with special emphasis on oxidative stress. Rorschach (Switzerland): Löpfe-Benz AG; 1998.
15. Crichton RR, Danielson BG, Geisser P. Iron therapy with special emphasis on intravenous administration. 4th ed. Bremen (Germany): UNI-MED; 2008.
16. Jacobs P, Wood L, Bird AR. Better Tolerance of Iron Polymaltose Complex Compared with Ferrous Sulphate in the Treatment of Anaemia. Hematology. 2000;5:77-83. (Pubitemid 30410508)
17. Tuomainen TP, Nyyssonen K, Porkkala-Sarataho E, Salonen R, Baumgartner JA, Geisser P, et al. Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation. Nutr Res. 1999;19:1121-1132 (Pubitemid 29297738)
18. Langstaff RJ, Geisser P, Heil WG, Bowdler JM. Treatment of iron-deficiency anemia: a lower incidence of adverse effects with Ferrum Hausmann than ferrous sulfate. Brit J Clin Res. 1993;4:191-198 (Pubitemid 24092527)
19. Jacobs P, Johnson G, Wood L. Oral iron therapy in human subjects comparative absorption between ferrous salts and iron polymaltose J Med. 1984;15:367-372
20. Jacobs P, Wormald LA, Gregorg MC. Absorption of iron polymaltose and ferrous sulphate in rats and humans. S Afr Med J. 1979;55:1065-1072
21. Geisser P. Safety and efficacy of iron(III)-hydroxide polymaltose complex. Arzneimittelforschung. 2007;57:439-452
22. Devaki PB, Chandra RK, Geisser P. Effect of oral supplementation with iron(III)-hydroxide polymaltose complex on the immunological profile of adolescents with varying iron status. Arzneimittelforschung. 2007;57:417-425 (Pubitemid 47055992)
23. Devaki PB, Chandra RK, Geisser P. Effects of Oral Supplementation with Iron(III) Hydroxide Polymaltose Complex on the Hematological profile of Adolescents with Varying Iron Status: A single centre prospective placebo controlled study. Arzneimittelforschung. 2008;58:389-397
24. Manual of Laboratory Techniques National Institute of Nutrition (NIN). Ind C Med Res. 1983;1435.
25. National Psychological Corporation. Catalogue of psychological books and tests instruments and experimental materials (2002-2003). Agra (India): Bhargava bhavan.
26. Ramalingaswamy P. Weschler Adult Performance Intelligence scale form-PR. Manual of Indian adaptation of WAIS performance scale; 1974.
27. BarOn R, Parker JDA. BarOn Emotional Quotient Inventory: Youth Version (EQ-i:YV). Toronto (Canada): Multi-Health Systems; 2000.